risks related to the successful integration of the licensed asset with Pfizer’s business; disruption from the transaction making it more difficult to maintain business and operational ...

FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, ...

Other changes at Pfizer include Mikael Dolsten ... He will also cover business analytics, global commercial operations and patient and health impact, among others. Pfizer’s Consumer Healthcare ...

This caused Pfizer to change its tactics ... a generics behemoth with annual sales of around $19 to $20 billion and operations in 165 markets around the word. This era, though, was also marked ...

Inspired by his deep commitment to food science and technology, Joseph Hildebrand, MS, CCS, pursued a career in food ...

Today, companies across sectors including DLF, Pfizer, Zydus Wellness, One Mobikwik Systems, Restaurant Brands Asia, Bharat ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

Since President Donald J. Trump took office a second time on Jan. 20, leaders across the biotechnology and pharmaceutical ...

Michela Tindera Botox, the anti-wrinkle drug that’s been injected into countless celebrity foreheads. Today, it’s made by a major American pharmaceutical company. And Westport’s just one of many Irish ...